The Executive Committee of the Board of Directors of Panacea Biotec at its meeting held on 08 April 2019 has approved the allotment of 74,300 unrated, unlisted, redeemable, non-convertible debentures (NCDs), having the face value of Rs.1 lakh each, aggregating to Rs.743 crore on private placement basis.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
